KS

Kumarswamy Shreelakshmi

Active Director Director DIN 09198008
DIN 09198008 First appointment Jun 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2021
Shareholding value •••• Premium profile

About Kumarswamy Shreelakshmi

Data last updated:

Kumarswamy Shreelakshmi is a Director at Diagen Private Limited (since 2021). The company operates in Pharma. Diagen Private Limited reported revenue of ₹19.47 Cr (FY 2024).

DIN 09198008
Primary Designation Director
Industry Pharma
First Appointment 08 Jun 2021
Oldest Company Age 5 yrs
Largest company Diagen Private Limited · ₹19.47 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Diagen Private Limited U51909KA2021PTC148274
Director08 Jun 20212021₹19.47 Cr (FY 2024)Active

Board colleagues of Kumarswamy Shreelakshmi

NameDINCompanyDesignation
Varghese Martin09198007Diagen Private LimitedDirector

Directorship timeline

Open interactive timeline →
Diagen Private Limited
Premium access

Shareholding and investment profile for Kumarswamy Shreelakshmi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kumarswamy Shreelakshmi

Kumarswamy Shreelakshmi currently holds 1 directorship: Diagen Private Limited (Director, since 08 Jun 2021, revenue ₹19.47 Cr (FY 2024)).

Kumarswamy Shreelakshmi was first appointed on 08 Jun 2021 as Director at Diagen Private Limited.

The current boards of Kumarswamy Shreelakshmi's companies include Varghese Martin (Diagen Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available